U.S., March 17 -- ClinicalTrials.gov registry received information related to the study (NCT07475000) titled 'Second Dose of Varicella Vaccine in Healthy Children' on Feb. 11.
Brief Summary: This study aim to assess the immunogenicity and safety of interchangeable administration of the second dose of varicella vaccine. A total of 300 healthy participants aged 15 months - 12 years will be enrolled. Written informed consent form will be obtained from participants' parents or legally acceptable representatives (and assents will be obtained from participants aged above 9 years old and written consent forms will be prepared and consent will be obtained in writing if possible from the participants aged 3-8 years old.) before enrollment. Particip...